| Filed On | Filing |
|---|---|
| 10 Jun 2022 |
Form 4/A: Humphries William D., Director
Granted 11,842 Non-employee Director Stock Option (right to buy) · Granted 2,538 Restricted Stock Units |
| 20 May 2022 |
Form 4/A: Hutson Nancy J, Director
Bought 3,000 shares ($9.24K) |
| 03 Sep 2021 |
Form 4/A: Arnold Susan Elizabeth, VP, Preclinical and Chem
Received 4,519 shares by exercise or conversion ($7.86K) |
| 03 Sep 2021 |
Form 4/A: Sharp John P, Chief Financial Officer
Received 7,500 shares by exercise or conversion ($12.6K) |
| 13 Dec 2018 |
Form 4/A: Mow Jonathan P, Director
Bought 700 shares ($2.72K) · Bought 800 shares ($3.08K) |
Loading...